SMG
ABBV icon

Smart Money Group’s AbbVie ABBV Stock Holding History

Smart Money Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
4,967
+35
+0.7% +$7.76K 0.31% 44
2025
Q4 		$1.13M Buy
4,932
+110
+2% +$25.1K 0.33% 39
2025
Q3 		$1.12M Buy
4,822
+54
+1% +$11K 0.33% 40
2025
Q2 		$885K Buy
4,768
+43
+0.9% +$7.99K 0.28% 50
2025
Q1 		$990K Sell
4,725
-128
-3% -$24.9K 0.34% 30
2024
Q4 		$862K Buy
4,853
+43
+0.9% +$7.91K 0.3% 55
2024
Q3 		$981K Buy
4,810
+50
+1% +$9.33K 0.35% 46
2024
Q2 		$882K Sell
4,760
-2,677
-36% -$443K 0.32% 48
2024
Q1 		$1.21M Buy
7,437
+1,004
+16% +$173K 0.47% 39
2023
Q4 		$997K Buy
6,433
+267
+4% +$38.9K 0.43% 37
2023
Q3 		$919K Buy
6,166
+530
+9% +$77.8K 0.44% 36
2023
Q2 		$759K Buy
5,636
+539
+11% +$79K 0.36% 38
2023
Q1 		$770K Buy
5,097
+121
+2% +$18.5K 0.39% 30
2022
Q4 		$804K Buy
4,976
+184
+4% +$28.2K 0.42% 27
2022
Q3 		$643K Buy
4,792
+45
+0.9% +$6.46K 0.44% 25
2022
Q2 		$727K Buy
4,747
+48
+1% +$7.33K 0.5% 28
2022
Q1 		$762K Buy
4,699
+42
+0.9% +$6.1K 0.51% 34
2021
Q4 		$631K Buy
4,657
+49
+1% +$5.79K 0.4% 42
2021
Q3 		$497K Buy
4,608
+627
+16% +$71.6K 0.36% 42
2021
Q2 		$391K Sell
3,981
-508
-11% -$57.2K 0.45% 31
2021
Q1 		$486K Buy
4,489
+168
+4% +$18K 0.41% 42
2020
Q4 		$463K Buy
4,321
+285
+7% +$27.4K 0.39% 35
2020
Q3 		$354K Buy
4,036
+55
+1% +$5.18K 0.15% 74
2020
Q2 		$391K Buy
+3,981
New +$351K 0.23% 59
2018
Q1 		– Sell
-2,230
Closed -$216K – 54
2017
Q4 		$216K Buy
+2,230
New +$210K 0.34% 37

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Smart Money Group's ABBV Position: Q1 2026 in Review

Smart Money Group increased its AbbVie (ABBV) stake by 0.71% in Q1 2026, buying an estimated $7.76K and bringing the position to 4,967 shares worth $1.08M. The position accounts for 0.31% of the portfolio, ranked #44.

Smart Money Group first reported a position in ABBV in Q4 2017 and has held it in 25 quarters since. The position peaked at $1.21M in Q1 2024. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Smart Money Group held 4,967 shares of AbbVie worth $1.08M as of Q1 2026.
  • Smart Money Group bought 35 AbbVie shares in Q1 2026, an estimated $7.76K.
  • AbbVie made up 0.31% of Smart Money Group's portfolio in Q1 2026, its #44 holding.
  • Smart Money Group first reported a position in AbbVie in Q4 2017 and has held it in 25 quarters since.
  • Smart Money Group's AbbVie position peaked at $1.21M in Q1 2024.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Smart Money Group's 13F filing for Q1 2026, filed 5 May 2026.